In the human pathogen Staphylococcus aureus, there exists an enormous diversity of proteins containing DUFs (domains of unknown function). In the present study, we characterized the family of conserved staphylococcal antigens (Csa) classified as DUF576 and taxonomically restricted to Staphylococci. The 18 Csa paralogues in S. aureus Newman are highly similar at the sequence level, yet were found to be expressed in multiple cellular locations. Extracellular Csa1A was shown to be posttranslationally processed and released. Molecular interaction studies revealed that Csa1A interacts with other Csa paralogues, suggesting that these proteins are involved in the same cellular process. The structures of Csa1A and Csa1B were determined by X-ray crystallography, unveiling a peculiar structure with limited structural similarity to other known proteins. Our results provide the first detailed biological characterization of this family and confirm the uniqueness of this family also at the structural level. We also provide evidence that Csa family members elicit protective immunity in in vivo animal models of staphylococcal infections, indicating a possible important role for these proteins in S. aureus biology and pathogenesis. These findings identify the Csa family as new potential vaccine candidates, and underline the importance of mining the bacterial unknown proteome to identify new targets for preventive vaccines.
INTRODUCTION
Staphylococcus aureus is a commensal bacterium that may colonize over 30 % of healthy adults, which is associated with increased risk of infection [1, 2] . S. aureus is also one of the most common opportunistic pathogens of humans and causes a wide range of diseases ranging from mild skin infections to lifethreatening endocarditis, toxic shock and necrotizing pneumonia in both hospital and community settings [3, 4] . Indeed, S. aureus is a leading cause of nosocomial infections worldwide [5] , and most of these infections are associated with bacteraemia and sepsis, and lead to death in 20 % of cases [6] .
The burden of staphylococcal disease is increasing due to the ability of S. aureus to acquire resistance to various antibiotics including methicillin and vancomycin [7] [8] [9] . MRSA (methicillinresistant S. aureus) has been recognized as a major cause of infections in healthcare settings and community environments [10, 11] . For example, in 2005 in the U.S.A., it was estimated that invasive MRSA infections occurred at a rate of >30 per 100 000 subjects, and caused over 18 000 patient deaths [6] . The alarming increase in multi-antibiotic resistance of S. aureus together with the wide variety and severity of staphylococcal infections pose a threat to public health and challenge our ability to control the disease, in particular due to the lack of an effective vaccine [12] [13] [14] .
Consequently, the understanding of staphylococcal physiology and pathogenesis is of great medical importance and has led to extensive S. aureus whole-genome sequencing programmes. The rapidly increasing volume of bacterial sequence data generated for staphylococci represents a tremendous resource for the identification of many new genes involved in virulence or drug resistance [15, 16] . Currently, the complete genomes of more than 100 staphylococcal strains have been sequenced, and whole proteome sets from 23 strains are annotated in the UniProt Knowledgebase [17] . As already observed in other organisms, S. aureus genomes revealed a set of proteins, up to 35 % of the total ORFs, which were annotated as 'putative uncharacterized proteins' or 'hypothetical proteins'. This class of proteins typically lacks any functional annotation despite most of them being real and many being evolutionarily conserved and organized in families on the basis of their sequence similarity and the presence of domains of unknown function, i.e. DUFs [18, 19] . In recent years, a co-ordinated effort to characterize DUFs from different organisms has been undertaken, since it is anticipated that the discovery of their functions will reveal new biological pathways and roles [18, 19] .
The present study focused on the previously uncharacterized family of conserved staphylococcal antigens (Csa), classified as DUF576, which appears to be taxonomically restricted to Staphylococci. We characterized the Csa family by obtaining data on expression, cellular localization, post-translational processing and molecular interactions. In addition, we determined the threedimensional structures of two different members of the Csa family. We also used mouse models to demonstrate that members of the Csa family are able to confer protective immunity against S. aureus, indicating that this family contains new candidates for the development of an effective vaccine against S. aureus.
EXPERIMENTAL Bacterial strains and culture conditions
Escherichia coli BL21(DE3) and DH5α cells were cultivated in LB broth. S. aureus NCTC 8325 and Newman strains used in the present study were grown in TSA (tryptic soy agar) or TSB (tryptic soy broth) at 37
• C. The antibiotic chloramphenicol (Sigma) was added at 10 μg/ml when appropriate.
Subcellular fractionation and Csa expression analysis
To analyse the subcellular distribution of Csa1A in S. aureus Newman, bacteria and supernatant were collected from 50 ml cultures (3000 g for 20 min). The supernatant was filtered (0.2 μm pore size) and diluted 1:1 with a Hepes/salt buffer (10 mM Hepes, 150 mM NaCl, 5 mM KCl, 1 mM MgCl 2 and 2.5 mM CaCl 2 , pH 7.4). Using Amicon Ultra centrifugal filter units (Millipore) with 3 kDa molecular-mass cut-off membranes, the supernatant was 100× concentrated to 0.5 ml. The bacterial pellet was washed once with PBS, resuspended in lysostaphin buffer [50 mM Tris/HCl, pH 6.8, 40 % sucrose and 100 μg/ml lysostaphin (Sigma)] and incubated for 1 h at 37
• C. After centrifugation at 14 000 g for 5 min, the pellet was resuspended in 50 mM Tris/HCl (pH 6.8) followed by three cycles of freeze and thaw. By centrifugation at 14 000 g for 5 min, cytosolic proteins were separated from the membrane-enriched protein fraction that was completely dissolved by addition of 2 % SDS solution and boiling at 95
• C. For expression analysis, proteins were separated by SDS/PAGE and transferred on to PVDF membranes for immunoblotting with a polyclonal anti-Csa1A antibody. To investigate the immunoreactive bands, a second SDS/PAGE run in parallel with the same protein samples was stained with Coomassie Blue and the respective bands were analysed by nano-LC-MS/MS followed by database search using Mascot (Matrix Science).
Cloning and purification of recombinant Csa proteins
Standard PCR strategies were used to amplify the S. aureus NCTC 8325 genes for csa1A, csa1B, csa1C, csa1D, csa2A, csa3B and csa4B. Primers were designed to generate a PCR product corresponding to the csa gene and harbouring complementary sequence sites to enable direct cloning into the pETTEV expression vector using the PIPE (polymerase incomplete primer extension) method [20] . The recombinant Csa proteins produced with this system carry a His 6 tag followed by a TEV (tobacco etch virus) cleavage site at its N-terminus. For the purification, E. coli BL21 transformants expressing the corresponding Csa proteins were washed and resuspended in equilibration buffer (50 mM sodium phosphate and 300 mM NaCl, pH 8.0) before mechanical lysis by sonication. The unbroken cells and bacterial debris were removed by centrifugation and recombinant His 6 -tagged Csa protein was purified from the supernatant by IMAC (immobilized metalion-affinity chromatography) purification using nickel-activated chelating Sepharose columns (His-trap FF; GE Healthcare) according to the manufacturer's instructions. Unbound proteins were removed by washing the resin with equilibration buffer supplemented with 20 mM imidazole. Proteins bound to the resin were then eluted with equilibration buffer supplemented with 250 mM imidazole. To obtain detagged Csa proteins, the His 6 -tagged proteins were incubated overnight at 4
• C with TEV protease at a 10:1 ratio.
For protein crystallization, the clones of Csa1A and Csa1B were designed to include residues 6-255 and 10-256 respectively, according to the sequence numbering of the full-length Uniprot entries Q2G1Q1 (Csa1A) and Q2G1Q0 (Csa1B). Both recombinant Csa1A and Csa1B were expressed as His 6 -tagged fusion proteins using E. coli BL21 cells. SeMet (selenomethionine) derivatives of both Csa1A and Csa1B were expressed using SeMet-containing enriched M9 medium. All proteins were purified by a two-step purification procedure, which included Ni-NTA (Ni 2 + -nitrilotriacetate) and size-exclusion chromatography. To investigate the putative role of calcium on the structural stabilization of Csa1, CaCl 2 was added to the sample at a final concentration of 10 mM during the last step of purification and prior crystallization.
Affinity purification of Csa1A interactors and MS
Full-length Csa1A was generated in-frame with two consecutive tags: the sequences of the FLAG tag and the SBP (streptavidinbinding peptide) tag at the C-terminus and cloned into plasmid pAM401 [21] . Newman wild-type strain was transformed with the resulting plasmid pAM TAP (tandem affinity purification)-Csa1A, and the expression of Csa1A in the supernatant was confirmed by immunoblotting with a mouse polyclonal antiCsa1A antibody and an HRP (horseradish peroxidase)-conjugated mouse anti-FLAG antibody. After overnight incubation at 37
• C, the supernatant of a 1.2 litre culture containing TAP-Csa1A was harvested, filtered through a 0.2 μm pore-size filter and diluted 1:1 with buffer A [10 mM Hepes, pH 7.5, 150 mM NaCl, 0.4 % Nonidet P40 and Complete TM protease inhibitor cocktail tablets (Roche)]. Using Amicon-stirred cells (Millipore) with 10 kDa molecular-mass cut-off membranes (Ultracel regenerated cellulose membranes; Millipore) the supernatant was first concentrated to 100 ml followed by a further concentration step using Amicon Ultra centrifugal filter units (Millipore) to reach a final volume of 12 ml. In parallel, the same procedure was performed with the negative control sample containing the empty pAM vector. The concentrated supernatant fraction was used as starting material for the affinity purification.
For the affinity purification of Csa1A interactors, sample preparation and MS were carried out essentially as described previously [22] .
Proteins were reduced and alkylated with iodoacetamide, and separated on a NuPage ® 4-12 % Bis-Tris gradient gel (Invitrogen). Gel lanes were cut into 16 slices across the separation range and in-gel digested with trypsin, and the peptide extracts were labelled with iTRAQ TM reagent (AB/Sciex; reagent 116 vector control, reagent 117 Csa1). Corresponding samples were mixed and analysed using an Eksigent NanoLC 1D + HPLC coupled to a Thermo LTQ-Orbitrap XL mass . For high-confidence protein identifications (<1 % false discovery rate at protein level), reporter ion signal intensities from all spectral matches for a given peptide sequence and modification state were summed for each reporter ion type and corrected according to the isotope correction factors given by the manufacturer. Only peptides unique to a given protein within the total dataset of identified proteins were used for relative protein quantification. Peptide fold changes were calculated for vector control over Csa1A, protein fold changes were derived as median peptide fold change and P values were calculated using a one-way Student's t test.
Processing site identification
The affinity pull-down applied to the supernatant sample of TAPCsa1A concentrated from 350 ml of culture was performed as described above. After binding of the SBP tag of Csa1A to the streptavidin beads, the sample was washed using stringent solutions: beads were incubated for 10 min at room temperature (25
• C) with 1 ml of the following solutions:
methanol, or (vii) distilled water. After standard biotin elution, the purified TAP-Csa1A was run on SDS/PAGE, and the respective protein band was in-gel digested with 200 ng of AspN (Sigma) in 100 mM Tris/HCl (pH 8.5) at 37
• C overnight, followed by ZipTip (Millipore) purification using a C 18 resin following the manufacturer's instructions. The samples were analysed by LC-MS/MS followed by database search using Mascot.
SPR (surface plasmon resonance)
Recombinant Csa1A [300 RU (response units)] was covalently immobilized in 10 mM acetate (pH 5.5) using a CM5 sensorchip, amine-coupling kit and HBS (Hepes-buffered saline: 20 mM Hepes and 150 mM NaCl, pH 7.4) as running buffer in a Biacore T200 system (GE Healthcare). Binding was measured at 25
• C at different concentrations (0-10 μM) of Csa proteins in running buffer in the presence or absence of metal ions, e.g. 1 mM ZnCl 2 .
DSF (differential scanning fluorimetry)
The shift of the melting temperature (T m ) of Csa1A was determined by DSF analysis following standard protocols [23] . . The plate was subjected to a temperature gradient scan • C) with a scan rate of 1
• C/min in a real-time PCR machine (Stratagene). The fluorescence intensity was measured using 5× SYPRO ® Orange dye (Invitrogen) with excitation/emission wavelengths of 490 and 575 nm respectively.
Protease-resistance studies
For protease-resistance studies, 30 μg of recombinant Csa protein in a final volume of 60 μl in TBS was incubated for 25 min at 37
• C in the presence or absence of ZnCl 2 or CaCl 2 (0, 0.1, 1 or 10 mM). Then, 0.3 μg of trypsin was added and incubated further at 37
• C. At various time points (0, 20, 60, 90, 120 and 240 min), a 10 μl aliquot was taken from each digestion sample and separated by SDS/PAGE on a 4-12 % gradient gel (Invitrogen).
Crystallization, data collection and structural determination
Crystallization experiments were carried out in 96-well lowprofile Intelli-Plate TM (Art Robbins) and 96-well low-profile Greiner crystallization plates, using a nanodroplet sitting-drop vapour-diffusion format. Equal volumes of protein samples and crystallization buffers were mixed using a Gryphon robot (Art Robbins), for a total drop volume of 400 nl, and incubated at both 20
• C and 4
• C. Crystals of Csa1A grew at 4
• C in 28% PEG 3350/0.157 M sodium thiocyanate (pH 6.9), whereas crystals of SeMet-Csa1B grew at 20
• C in 37% MPD (2-methyl-2,4-pentanediol)/PEG 1000/PEG 3350, 0.1 M Morpheus buffer 3 and 10 % Morpheus alcohols (condition D12 of Morpheus screen from Molecular Dimensions). All crystals were mounted in cryoloops using 10 % ethylene glycol and 10 % glycerol as cryoprotectant for Csa1A and Csa1B respectively, before cooling to 100 K for data collection.
X-ray diffraction data from crystals of Csa1A and SeMetCsa1B were collected at beamlines 5.0.2 and 5.0.3 of the ALS (Advanced Light Source), Berkeley, CA, U.S.A., and ID14 of the ESRF (European Synchrotron Radiation Facility), Grenoble, France, respectively. All diffraction data were processed with HKL2000 [24] and iMosflm [25] . Crystals of Csa1A belong to space group P2 1 , with unit cell dimensions a = 71.1, b = 49.2, c = 137.3, and α = 90, β = 89.9, γ = 90, and contain four molecules in the asymmetric unit (Matthews coefficient 2.23 Å 3 ·Da − 1 , for a solvent content of 45 %; 1 Å = 0.1 nm). The presence of pseudo-merohedral twinning for the crystal form of Csa1A was detected using phenix.xtriage [26] , with a fraction of 0.49 and twin law h, − k, − l, which was utilized during refinement in phenix. Crystals of Csa1B belong to space group P2 1 2 1 2 1 , with unit cell dimensions a = 69.1, b = 73.4, c = 46.6, and contains one molecule in the asymmetric unit (Matthews coefficient 2.19 Å 3 ·Da − 1 , for a solvent content of 44 %). The structure of Csa1B was solved by SeMet SAD (singlewavelength anomalous dispersion) phasing, at 2.3 Å resolution. Substructure solution, phasing, density modification and initial model building were performed with autosol and autobuild in Phenix [26] . Subsequent manual refinement and building was performed with Phenix and Coot [27] . Csa1B regions that were not visible in the electron-density maps and thus were not included in the final refined model include residues 10-33, 163-167, 175-180, 218-227 and 254-256.
The crystal structure of Csa1A was subsequently solved by molecular replacement in Phaser [28] at 2.5 Å, using the final refined model of Csa1B as a search model, followed by refinement and building with Phenix [26] and Coot [27] . Regions that could not be modelled because of lack of electron-density map include residues 6-39, 113-121, 162-181, 215-226 and the last C-terminal residues 253-255 in chain A; residues 6-42, 58-62, 111-120, 165-181, 215-226 and 253-255 in chain B; residues 6-38, 113-120, 165-181, 215-226 and 253-255 in chain C; and residues 6-39, 54-64, 112-120, 164-181, 215-226 and 253-255 in chain D. Model analysis was carried out with DALI [29] , and pictures were generated with CCP4MG [30] . All other crystallographic manipulations were carried out with the CCP4 package [31] . Data collection and refinement statistics for both structures are shown in Table 1 .
Renal abscess model
Five-week-old CD1 mice (Charles River Laboratories) were immunized intraperitoneally with prime-booster injections of 200 μl containing 20 μg of purified Csa protein adsorbed to aluminium hydroxide adjuvant (2 mg/ml) with a 14-day interval. Control mice received equal amounts of PBS and aluminium hydroxide adjuvant. Overnight cultures of S. aureus Newman strain were diluted 1:100 into fresh TSB and grown at 37
• C with shaking until reaching mid-exponential phase. Bacteria were centrifuged, washed with PBS and suspended in a volume of PBS to yield approximately 5×10 9 CFU (colony-forming units)/ml. The inoculum was verified experimentally by plating on to TSA and colony enumeration.
Immunized animals were challenged on day 24 by intravenous injection of a sub-lethal dose of S. aureus Newman. After 4 days, on day 28, mice were killed and kidneys were removed and homogenized in 1 % Triton X-100 and plated on agar medium in triplicate for determination of CFU.
Three independent experiments were carried out under the same conditions to assess reproducibility. The data were analysed using Prism Graph Pad 5 software with statistical assessment using the Mann-Whitney U-test.
Animal experimentation
Mice were monitored daily and killed at the appearance of humane end points, in accordance with Novartis Animal Welfare Policies and Italian law. Experimental protocols were reviewed and approved by the Italian National Institute of Health (Istituto Superiore di Sanità), with protocol number 21/2009-B.
RESULTS

In silico identification of the Csa family
Genomic analysis of the S. aureus strain NCTC 8325 revealed a family of related sequences organized in four distinct ORF loci. Each locus was found to contain multiple paralogous genes, i.e. four genes (A, B, C and D) in locus 1, one gene in locus 2, three genes in locus 3 and three in locus 4. Consequently, we adopt hereinafter a nomenclature system for these Csa proteins wherein, for example, the four proteins in locus 1 are termed Csa1A, Csa1B, Csa1C and Csa1D, whereas Csa2A defines the locus 2 paralogue and so on. The extent of amino acid similarity within the Csa family ranges from 54 % (comparing Csa2A with Csa3C) to 91 % (Csa1A with Csa1C) ( Figure 1A ). The genetic organization of the Csa family in multiple loci each containing a variable number of paralogues is conserved in all S. aureus strains sequenced so far, including the Newman strain central to the present study ( Figure 1B ). Locus tags corresponding to the csa genes are reported in Supplementary  Table S1 (http://www.biochemj.org/bj/455/bj4550273add.htm).
Csa sequences are highly conserved across different strains and have been annotated as a protein family in the Pfam database [32] . Since sequence BLAST searches did not reveal any known functional domains or any significant similarity towards proteins of known function in other organisms, the Csa family has been classified by the presence of DUF576. At the genomic level, the DUF576 protein family is present in all S. aureus strains sequenced so far and it is taxonomically restricted almost exclusively to staphylococci where it is present in 85 strains for a total of 1062 sequences. The DUF576 occurs very rarely in other organisms, with only two sequences identified in Listeria grayi, one in Streptococcus sanguinis and one in Catonella morbi.
Csa proteins are expressed in all growth phases in the membrane fraction
In order to investigate the expression and localization properties of the Csa proteins, we performed in silico and experimental localization studies.
Although overall very similar at the sequence level, different localizations of the Csa family paralogues were predicted in silico using SignalP 4.0 [33] and PredLipo [34] in S. aureus Newman. Owing to the presence of both a signal peptide and a lipoprotein consensus sequence, 15 Csa family members were predicted to be localized at the bacterial membrane. However, for Csa2A, Csa4A and Csa4B, a signal peptide, but no lipoprotein signal sequence was identified, indicating the likely secretion of the proteins and predicting an extracellular localization of those three paralogues (Supplementary Table S1 ). Table S1 at http://www.biochemj.org/bj/455/bj4550273add.htm.
Csa1A was chosen for further investigation due to its conservation in all sequenced strains; indeed, Csa1A was classified previously within the 'core lipoproteome' of S. aureus [35] . Its localization was studied experimentally by subcellular fractionation analysis followed by MS. Concentrated supernatant and membrane-enriched fractions were prepared from wildtype S. aureus Newman cultures at early-exponential, lateexponential and stationary growth phases. The different fractions were analysed by immunoblotting using pooled sera obtained from mice after immunization with recombinant Csa1A. A positive immunoreactive signal was detected in the membraneenriched fraction derived from all growth phases, and MS analysis confirmed the presence of a peptide shared by several different Csa members in all of these bands together with two Csa3I-specific peptides (Figure 2 ). This finding is in agreement with previous identification obtained by large-scale proteomics-based analysis of the staphylococcal membrane fraction by 1D-gel-LC-MS/MS and 2D-gel-LC-MS/MS where the corresponding paralogue in S. aureus COL, i.e. SACOL0486, was consistently identified by the two methods [36] .
Samples obtained from the supernatant exhibited a positive immunoreactive signal only upon reaching the stationary growth phase and not in the early-or late-exponential phases. The MS analysis on this latter band identified five peptides: one peptide shared by locus 1 and locus 3 sequences, two peptides shared by locus 1 sequences only, and two peptides that could be specifically attributed solely to Csa1A. Thus Csa1A was identified as being released into the supernatant during the stationary growth phase in the Newman strain (Figure 2 ). Similar data identifying Csa1A in the secreted proteome of two clinical isolates grown at early stationary phase have been reported previously [37] . However, to date, no information is available on the mechanism of release of Csa1A. 
Csa1A is released into the supernatant by N-terminal processing
In principle, proteins with a lipoprotein signal peptide are exported via the Sec pathway and retained on the extracellular face of the bacterial membrane by lipid modification of the invariant cysteine residue present in the lipobox [38] . However, there is increasing evidence that some lipoproteins can be released into the extracellular milieu by proteolytic removal of the Nterminal cysteine residue that contains the diacylglyceryl moiety, as reviewed previously [35] . The release process has been well documented in Bacillus subtilis, where a "lipoproteinreleasing consensus pattern" was also identified as C- [39, 40] . In the case of S. aureus, the composition of the exoproteome has been explored extensively under different conditions and by different analytical methods [36, 37, [41] [42] [43] [44] . None of the lipoproteins identified in culture supernatants, including Csa1A, matched the B. subtilis consensus pattern, suggesting that the pattern is not applicable to S. aureus. However, a high conservation of glycine at the + 2 position was observed in both B. subtilis and S. aureus sequences, suggesting that this residue can be important for lipoprotein release into the growth medium, whereas serine at this same position seems to inhibit the process [35] . Since Csa1A shows glycine in position + 2 (Supplementary Table  S1 ), we carried out further experiments to study the hypothetical processing event responsible for its release into the extracellular compartment. MS experiments were performed with the aim of identifying the N-terminal peptide and consequently the possible proteolytic cleavage site. In order to obtain a purified sample of the mature Csa1A protein released, analyses were performed using a modified S. aureus Newman strain expressing the recombinant Csa1A fused to the tandem FLAG and SBP tags at the C-terminus that can be applied to the affinity-purification technique called TAP. This recombinant TAP-Csa1A construct spanning the whole sequence included its N-terminal signals for secretion and lipidation in order to maintain the correct localization and maturation process. As a control, the empty plasmid was used. Monitoring the expression of tagged Csa1A by immunoblotting, it was demonstrated that the protein was detected in the culture supernatant at stationary phase consistent with the localization of the wild-type protein (Supplementary Figure S1 at http://www.biochemj.org/bj/455/bj4550273add.htm). These data showed that the tagged Csa1A protein might be used to clarify the characteristics of the Csa1A protein form present in vivo in the bacterium and to unravel the steps that take place to achieve its final localization in the supernatant.
TAP-Csa1A protein was affinity-purified from culture supernatant, separated by SDS/PAGE, and the band obtained was investigated by MS analysis after digestion with trypsin or AspN. Peptide mass fingerprint analysis confirmed the identification of the TAP-Csa1A protein in both digestion samples with the number of peptides varying from four (AspN digestion) to seven (trypsin digestion) (Figure 3) . A peptide starting at Thr 40 (corresponding to Thr 39 in S. aureus NCTC 8325) was identified in both digestions. The data obtained using trypsin did not provide any information on the possible N-terminal processing event since the TLSMYPIK peptide identified could have derived from a tryptic cleavage. However, data obtained upon treatment with the AspN enzyme revealed a truncated peptide, TLSMYPIKNLE, that did not contain an N-terminal cleavage site of the enzyme. These data clarified that the start of this peptide results from a cleavage event on the protein before the AspN digestion and showed that the Csa1A protein present in the supernatant was processed to yield a mature form starting at Thr 40 , located 15 residues C-terminal to the lipidation site (Cys 25 ).
Csa1A interacts with its paralogues
An affinity proteomics approach was used to identify interaction partners of Csa1A present in S. aureus. Since the results from immunoblot and MS/MS analysis identified the mature form of Csa1A in the supernatant, the purification of affinity-tagged Csa1A and its interactors was performed using this fraction. Supernatants harvested from S. aureus Newman cultures expressing either Csa1A carrying the C-terminal TAP tag consisting of an SBP for purification and a FLAG peptide primarily for detection or the empty vector were subjected to streptavidin enrichment, and tagged Csa1A proteins along with its interacting proteins present in the bacterial supernatant were eluted using excess biotin.
Proteins from both samples were separated by 1D-SDS/PAGE (Supplementary Figure S2 at http://www.biochemj.org/bj/455/ bj4550273add.htm) and subsequently analysed by quantitative MS using stable isotope labelling tags.
Out of 176 high-confidence identifications of S. aureus proteins, candidate interactors were prioritized on the basis of their enrichment in the TAP-Csa1A sample over vector control. These selection criteria resulted in the identification of Csa1A and four additional members of the Csa protein family, Csa1B, Csa1D, Csa2A and Csa3H, as candidate interaction partners of Csa1A. It should be noted that despite the high homology of Csa1A and the other Csa family members, unique peptides for each of these family members were sequenced and quantified by MS.
Csa1A-paralogue interactions are regulated by zinc
The TAP-MS results pointed to the formation of complexes between different members of the Csa protein family. We purified recombinant forms of Csa1A and its paralogues and investigated their interactions by SPR. Owing to the relatively high proportion (>16 %) of acidic residues in Csa1A and other Csa family proteins, we tested whether divalent metal cations might regulate the interactions of Csa1A with its paralogues. The self-association of Csa1A, and its binding to Csa1B, and Csa1D was dependent on the presence of Zn 2 + ions in the running buffer (Supplementary Figure S3A at http://www.biochemj.org/bj/455/bj4550273add.htm). In contrast, the interaction between Csa1A and the paralogue Csa4B was observed in the absence of metal ions and was abolished in the presence of zinc (Supplementary Figure S3A) . The injection of increasing concentrations in the micromolar range (0-10 μM) of Csa1A, Csa1B and Csa1D over immobilized Csa1A revealed that, in the presence of Zn 2 + ions, these Csa proteins bound to Csa1A in a concentration-dependent manner (Supplementary Figure S3B) . The precise determination of binding affinities was not possible because the SPR sensorgrams could not be reliably fitted to any available interaction model, perhaps due to the heterogeneity of ligand and/or analyte preparations, i.e. the highly purified proteins were in monomer-dimer equilibrium, as confirmed by cross-linking experiments (see the Supplementary Online Data and Supplementary Figure S3C) . The effect of Zn 2 + ions on Csa family interactions are summarized in Table 2 .
Effect of metal ions on structural stabilization
To evaluate whether metal ions might have any direct influence on the overall stability of Csa1A, we investigated the effect of different bivalent ions at physiological concentrations using DSF (Supplementary Figure S4 at Figure S4) . To Figure S5 at http://www.biochemj.org/bj/455/bj4550273add.htm). Interestingly, the addition of Zn 2 + ions increased the resistance to trypsin digestion for all Csa proteins tested except for Csa1B. In contrast, in the presence of Ca 2 + ions, Csa1A and Csa1D became more resistant, whereas Csa1B showed a decrease in its resistance to protease. Moreover, the addition of Ca 2 + had no effect on Csa1C, Csa2A or Csa3B. These data are summarized in Table 3 .
Overall structures of Csa1A and Csa1B
In order to characterize the Csa family and DUF576, we solved the crystal structures of Csa1A and Csa1B. We first produced crystals of recombinant Csa1A (lacking the signal peptide), both in native and in SeMet forms. Whereas the native crystals diffracted the X-rays up to 2.5 Å, the SeMet crystals were of lower quality, diffracting the X-rays below 3.5 Å. This did not allow us to measure an anomalous signal suitable for structure determination by experimental phasing, and the lack of homologous structures in the PDB initially hampered our attempts at solving the structure. As a strategy to obtain improved crystals, we crystallized the paralogue Csa1B, which shares 76 % sequence identity with Csa1A, and readily obtained crystals of the SeMet form. These Csa1B crystals diffracted X-rays up to 2.3 Å, with anomalous signal extending up to 2.8 Å.
The structure of Csa1B was solved by SAD methods, and refined to an R factor of 22.5 % (R free 26.2 %) ( Table 1) . The final refined model of Csa1B includes one molecule in the asymmetric unit and spans Lys 34 -Ser 253 . Regions of the original purified protein used for crystallization that were not visible in electron-density maps include the first eight N-terminal residues, the last three C-terminal residues and three short unstructured loops connecting β-strands in the N-terminal region (see the Experimental section for full details).
The structure of Csa1B exhibits a single α/β domain arranged as a large ten-stranded antiparallel β-sheet that closely resembles a β-half-barrel fold ( Figure 4A , and Supplementary Figures S6A and S6B at http://www.biochemj.org/bj/455/bj4550273add.htm). The strand order of the β-sheet is 6-7-8-9-10-1-2-3-4-5. Five α-helices are located on the convex side of the half-barrel, and are connected by loops. Two helices are located at the Nterminal region, and a third and fourth short helix lie within a long loop connecting strands 5 and 6 and which traverses the entire β-sheet. The C-terminal helix connects β-strands 7 and 8. High temperature factors were observed for several loops connecting the strands of the β-sheet, and three loop regions lacked electron density and were not modelled in the final coordinates ( Figure 4A) .
The fully refined co-ordinates of Csa1B were subsequently used as the input template model to solve the crystal structure of Csa1A by molecular replacement at 2.5 Å resolution. Crystals of Csa1A contained four molecules in the asymmetric unit, arranged as two independent dimers of Csa1A sharing a relatively small interface of only ∼200 Å 2 ( Figure 4B , and Supplementary Figures  S6C and S6D) . The relative orientation between monomers of Csa1A does not superimpose with the orientation between symmetry-related molecules in the unit cell of crystals of Csa1B (Supplementary Figures S6A and S6B) . Although the SPR and native gel experiments revealed a tendency of Csa proteins to dimerize, it is also possible that the dimeric crystallographic arrangements observed may be due to constraints dictated by the specific crystallographic packing.
A strong positive peak in the difference Fourier electron density maps of Csa1A was observed at the surface of Csa1A. Since a high concentration of CaCl 2 (10 mM) was present in the protein solution used for crystallization, this positive peak was modelled as a Ca 2 + ion ( Supplementary Figures S6C and S6D) . However, the resulting co-ordination of the modelled ion does not satisfy the commonly observed hexahedral configuration, and the Ca 2 + ion is located on the surface of the protein nearby the missing fragment of residues 162-181, thus opposite the dimerization face observed in the crystal structure. Thus, owing to some uncertainty in the binding of Ca 2 + to Csa1A as observed in our structure, we cannot speculate on the structural basis for stabilization of Csa1A by metal ions observed in our DSF experiments.
As expected due to their high sequence identity (75 %), the overall fold of Csa1A is identical with that of Csa1B, and superimposition of the two structures results in RMSD of 1.0 Å for 172 aligned Cα residues ( Figure 4C ). Residues of Csa1A that could not be built because of disorder as inferred by lack of electron densities include, as already observed in Csa1B, short fragments at the N-and C-termini, and three unstructured loops. In addition, the short strand β-6 is disordered in Csa1A (Figures 4C  and 4D ). The full list of disordered residues that were omitted from the final refined model for all four chains of Csa1A is reported in the Experimental section.
Structural comparison
Despite Csa1A and Csa1B sharing a virtually identical overall fold ( Figure 4C ), structural comparison revealed a prominent difference in the electrostatic potential distribution on the surface of the two proteins. A cluster of acidic aspartate and glutamate residues in Csa1A creates a large negatively charged patch on the concave base of the β-halfbarrel ( Figure 5A ). In contrast, the same region of Csa1B is neutral overall and is predominantly made of basic and polar amino group-containing residues ( Figure 5B ). Although hydrophobic residues are also located in this region of the Figure S7) Figure  S5) , suggesting the possible involvement of this region.
As expected, a search of the PDB [45] with the program DALI [29] revealed an overall similarity of Csa1A and Csa1B to several β-barrel-containing proteins, although with rather low sequence identities. The top two hits with strong structural homology (DALI Z scores >7) were the Mycobacterium tuberculosis lipoproteins LprG (RMSD of 4.3 Å for 135 Cα atoms) and LppX (RMSD of 3.9 Å for 126 Cα atoms), although they both share sequence identity below 10 % with the Csa1 proteins. LprG is a protein carrier that binds glycolipids [46] , and LppX may be a protein carrier able to translocate lipids across the cell envelope of M. tuberculosis [47] .
Whereas comparison with weaker structural homologues (Z scores <7) revealed only small portions of the β-barrel as the common structural elements with the Csa1 proteins, a structural comparison with LprG and LppX revealed overall highly similar folds featuring an antiparallel β-sheet of ten or 11 β-strands. However, in comparison with the Csa1 structures, the LprG and LppX folds have their α-helices on the opposite concave side of the β-sheet, and between these distinct secondarystructural elements lies a large cavity (volume 1500-3000 Å 3 ) that can accommodate lipophilic ligands. The different domain organization displayed by the Csa proteins essentially eliminates the space between their β-sheet and α-helices, making this region highly unlikely as a ligand-binding pocket. Indeed, neither a putative binding pocket nor a patch of hydrophobic residues could be detected in this area of the Csa1 structures, suggesting functional differences between these proteins despite similar overall folds, and confirming the uniqueness of the Csa family also at the structural level.
Csa proteins protect mice against S. aureus
In order to explore the Csa proteins as potential vaccine candidates against staphylococcal infections, the four Csa proteins from locus 1 were tested in a renal abscess infection model in mice. After immunization with adjuvant alone (control group) or with recombinant Csa1A, Csa1B, Csa1C or Csa1D proteins, mice were infected intravenously with sub-lethal inocula of S. aureus Newman. Four days after infection, kidneys of mockimmunized mice harboured bacterial abscesses with a central nidus of staphylococci. In contrast, mice vaccinated with Csa1A showed highly significant reduction of CFU counts in the kidneys 4 days after infection. A similar trend, although to a lesser extent, was observed following immunization with Csa1B and Csa1C. Protection generated by Csa1D immunization showed only a trend towards significance. However, the level of protection associated with the four antigens appeared to be comparable ( Figure 6 ).
DISCUSSION
In the present paper, we report the first studies of the staphylococcal Csa family classified by the domain of unknown function DUF576. We have provided novel information regarding distinct subcellular expression profiles, post-translational processing, molecular interactions and structure.
Taxonomically, the Csa family was shown to be largely restricted to S. aureus, where it is organized in multiple loci with a variable number of paralogues per locus. In the genomes of S. aureus NCTC 8325 and Newman strains analysed in the present study, csa genes are present in four loci collectively containing 11 and 18 paralogues respectively. The analysis of eight additional sequenced S. aureus strains confirmed that the organization in multiple loci is conserved in all known genomes [48] with one to five csa genes in locus 1; only one gene in locus 2 is present in all the strains except for RF122 and MRSA252 in which the gene is lacking; three to ten csa homologues in locus 3, and one to four tandemly repeated csa genes, sometimes with intervening ORFs, in locus 4. The Csa locus 3 was found to be part of the genomic island νSaα that also carries the staphylococcal exotoxin-like genes, although the meaning of this association has not yet been clarified [49, 50] . It was noted that all nine S. aureus strains investigated showed synteny along the entire genome and carry the csa genes at the same loci in the same orientation [48] . Moreover, it had been reported that the csa genes compose the largest group of paralogous genes in S. aureus strain N315 [51] .
With few exceptions, the Csa paralogues are annotated as tandem lipoproteins on the basis of the presence of a characteristic consensus sequence. Biosynthesis of lipoproteins in Gram-positive bacteria is a three-step pathway, involving (i) translocation of the precursor across the membrane, (ii) lipidation of the thiol group of the cysteine residue present in the lipobox by the diacylglyceryl transferase Lgt, and (iii) cleavage of the signal peptide by the lipoprotein-specific type II signal peptidase LspA. This process leaves the lipidated cysteine residue as the new N-terminal residue serving as the membrane anchor of the mature lipoprotein that extends out of the bacterial surface with the rest of the molecule [34, 52] . It has also been shown that lipoproteins can be released from the membrane into the extracellular compartment as reported in B. subtilis [39, 53] and other species, including S. aureus [37, 41, 54] . In agreement with our observations, the latter studies reported that Csa1A and other members of the Csa family are also released. In the present study, we investigated the mechanism of Csa1A release and we identified its N-terminal sequence, showing that Csa1A purified from culture supernatant had been released by a proteolytic cleavage in position + 14 from the lipidated cysteine residue, i.e. at Lys 39 ↓Thr
40
(corresponding to Lys 38 ↓Thr 39 in S. aureus NCTC 8325). These data suggest that a specific mechanism for lipoprotein release into the extracellular milieu by proteolytic cleavage exists in S. aureus. Considering the high degree of sequence conservation of the Csa members in this region and the experimental identification of multiple paralogues in the supernatant, it is likely that other Csa lipoproteins follow a processing event leading to their release. In previous studies carried out in B. subtilis, the lipoproteins OppA and YclQ were found to be cleaved one residue towards the C terminus of the lipidated cysteine residue in an lgt mutant as well as in the parental wild-type strain [39] . In the case of Csa1A, the processing led to the removal of a longer peptide, similar to lipoprotein shaving reported in Neisseria meningitidis [55] and in Mycoplasma fermentans [56] . Although the biological meaning of processing and release of surface lipoproteins into the supernatant remains to be determined, it clearly represents a common theme in different bacteria. As already speculated for other micro-organisms, this event might lead to the acquisition of new functional properties of both the lipopeptide and the rest of the mature protein that is released.
Our expression data showed that Csa proteins are present in the membrane at all growth phases and that a Csa1A processing event occurs during the stationary growth phase. Vaccination of mice with any of the Csa proteins from locus 1 protects them from lethal challenge with S. aureus, indicating that Csa proteins represent a completely new class of bacterial antigens able to confer protective immunity against staphylococcal infections. However, Csa1A induced the highest reduction of bacterial burden in the kidneys, suggesting a primary role for this paralogue as a vaccine candidate. Interestingly, the maximal expression of S. aureus secreted virulence factors occurs during the postexponential phase of growth [57] and therefore the release of mature Csa1A into the supernatant at stationary growth phase also suggests that Csa1A may play a role connected to S. aureus virulence.
The present study also reveals interactions between individual Csa proteins. In particular, we have shown that the interaction is not restricted to paralogues originating from the same genetic locus but spreads to paralogues from other loci, and that Zn 2 + ions regulate homo-and hetero-oligomerization. This suggests that Csa paralogues participate in the same cellular process in which each paralogue might contribute with a particular role, and that this process is modulated by metal ions. In support of this, we also report that Csa1A is able to bind to all bivalent ions tested, and, in addition, individual Csa proteins show different binding properties to Zn 2 + and/or Ca 2 + , leading to different structural stability and hence protease resistance.
The crystal structures of Csa1A and Csa1B reveal a peculiar fold that is likely to extend to all Csa proteins. Nevertheless, a detailed structural analysis revealed some interesting differences in their surface properties, which may explain their different metal-binding behaviours. These observations, together with their different subcellular localizations revealed a functional divergence within the Csa family members.
In conclusion, in the present study, we confirm the uniqueness of this class of proteins and we provide the first evidence that they are protective antigens with a possible role in virulence. Although the biological purpose served by this large family of conserved staphylococcal antigens remains to be elucidated, their highly conserved presence is presumably important for an essential function(s) that is specific to this pathogen.
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